Buy Bertizomeb 3.5mg Injection (German Quality) Online
Bertizomeb 3.5mg is a premium quality injectable containing Bortezomib, manufactured by Ever Pharma Jena GmbH in Germany. It is indicated for the treatment of patients with Multiple Myeloma and Mantle Cell Lymphoma.
Why Choose Ever Pharma (Germany)? Ever Pharma Jena is a world-renowned specialist in sterile injectables. Choosing the German version of Bertizomeb ensures you are receiving a product manufactured under the highest European pharmaceutical standards (EU-GMP), offering superior purity and reliability for critical cancer care.
Medical Indications:
Multiple Myeloma: Indicated as part of combination therapy (e.g., with Melphalan and Prednisone) for previously untreated patients or those who have relapsed.
Mantle Cell Lymphoma: Used for patients who have received at least one prior therapy.
Reconstitution & Administration:
Important: This drug must be reconstituted (mixed) by a healthcare professional before use.
Routes: It can be administered via Intravenous (IV) injection (3-5 seconds bolus) or Subcutaneous (SC) injection.
Warning: Intrathecal administration is contraindicated and fatal.
Clinical Pharmacology: Bortezomib works by inhibiting the 26S proteasome, a complex structure inside cells that breaks down proteins. By blocking this process, Bertizomeb causes a buildup of proteins that leads to cell cycle arrest and apoptosis (cell death) in cancer cells.
Frequently Asked Questions (FAQ):
Q: What is the difference between the German and Latvian versions? A: Both contain the same active ingredient (Bortezomib 3.5mg). The German version (Ever Pharma) is often preferred by patients seeking specific Western European manufacturing standards.
Q: How should I store this medicine? A: Store below 25°C. Keep the vial in the original carton to protect it from light.
Q: Is this product available for immediate delivery? A: Yes, subject to stock availability and valid prescription verification.
Reviews
There are no reviews yet.